Raja Luthra

2.8k citations

54 papers · 1.7k indexed · h-index 24

Hematology top 2%
- Chronic Myeloid Leukemia Treatments 17
- Acute Myeloid Leukemia Research 12
Genetics top 2%
- Chronic Lymphocytic Leukemia Research 15
- Myeloproliferative Neoplasms: Diagnosis and Treatment 10
Cancer Research top 5%
- Cancer Genomics and Diagnostics 11
Pathology and Forensic Medicine top 5%
Rheumatology top 5%
- Eosinophilic Disorders and Syndromes 8
Pulmonary and Respiratory Medicine
- Lung Cancer Treatments and Mutations 6
Oncology
- Colorectal Cancer Treatments and Studies 5

Co-authors: Hagop M. Kantarjian Jörge E. Cortes Keyur P. Patel Farhad Ravandi Srđan Verstovšek Patrick M. Lynch Mark J. Routbort Russell R. Broaddus
Cited by: Hematology Genetics Cancer Research
Journals: Journal of Clinical Oncology (4 papers)Blood (10 papers)PLoS ONE (3 papers)
Partner nations: United States Malaysia Italy

In The Last Decade

Raja Luthra

53 papers receiving 1.7k citations

Peers

Countries citing papers authored by Raja Luthra

Since Specialization

Citations

This map shows the geographic impact of Raja Luthra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raja Luthra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raja Luthra more than expected).

Fields of papers citing papers by Raja Luthra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raja Luthra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raja Luthra. The network helps show where Raja Luthra may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Raja Luthra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raja Luthra Line = papers co-authored together Raja Luthra links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	An Integrated Spatial, Codex, and Genomic Analysis Predicts Responsiveness and Survival in the Phase II Combination of Pembrolizumab and Romidepsin in PTCL Blood ·Ranjit Nair,Daniela Dueñas,Jingjing Liu,Rishab Prakash,Chen Zhou,Ayse Aslihan Koksoy,Jie Xu,Salomé McAllen,Luis Malpica,Raja Luthra,Francisco Vega,Roberto N. Miranda,Jianhua Zhang,L. Jeffrey Medeiros,Cara Haymaker,Christopher R. Flowers,Sattva S. Neelapu,Swaminathan P. Iyer	2024	1
2	Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA Testing JCO Precision Oncology ·Stefania Napolitano,Aparna R. Parikh,Jason T. Henry,Christine M. Parseghian,Jason Willis,Kanwal Raghav,Van K. Morris,Benny Johnson,Bryan K. Kee,Arvind Dasari,Michael J. Overman,Raja Luthra,Leylah Drusbosky,Ryan B. Corcoran,Scott Kopetz,Ryan Sun	2023	1
3	Clinical molecular testing for ASXL1 c.1934dupG p.Gly646fs mutation in hematologic neoplasms in the NGS era PLoS ONE ·Santiago Montes‐Moreno,Mark J. Routbort,Elijah J. Lohman,Bedia A. Barkoh,Rashmi Kanagal‐Shamanna,Carlos E. Bueso‐Ramos,Rajesh R. Singh,L. Jeffrey Medeiros,Raja Luthra,Keyur P. Patel	2018	18
4	Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer PLoS ONE ·Amir Mehrvarz Sarshekeh,Shailesh Advani,Michael J. Overman,Ganiraju C. Manyam,Bryan K. Kee,David R. Fogelman,Arvind Dasari,Kanwal Raghav,Eduardo Vilar,Shanequa Manuel,Imad Shureiqi,Robert A. Wolff,Keyur P. Patel,Raja Luthra,Kenna Shaw,Cathy Eng,Dipen M. Maru,Mark J. Routbort,Funda Meric‐Bernstam,Scott Kopetz	2017	64
5	Germline Mutation of T790M and Dual/Multiple EGFR Mutations in Patients With Lung Adenocarcinoma Clinical Lung Cancer ·Yanyan Lou,Chad V. Pecot,Hai T. Tran,Vikki Devito,Xi Tang,John V. Heymach,Raja Luthra,Ignacio I. Wistuba,Zhuang Zuo,Anne S. Tsao	2015	39
6	Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decade American Journal of Hematology ·Talha Badar,Hagop M. Kantarjian,Graciela M. Nogueras‐González,Gautam Borthakur,Guillermo Garcia‐Manero,Michael Andreeff,Marina Konopleva,Tapan M. Kadia,Naval Daver,William G. Wierda,Raja Luthra,Keyur P. Patel,Betül Oran,Richard E. Champlin,Farhad Ravandi,Jörge E. Cortes	2015	20
7	Detectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomes Leukemia Research ·Talha Badar,Keyur P. Patel,Philip A. Thompson,Courtney D. DiNardo,Koichi Takahashi,Mónica Cabrero,Gautam Borthakur,Jörge E. Cortes,Marina Konopleva,Tapan M. Kadia,Zach Bohannan,Sherry Pierce,Elias Jabbour,Farhad Ravandi,Naval Daver,Raja Luthra,Hagop M. Kantarjian,Guillermo Garcia‐Manero	2015	39
8	Analysis of 1,115 Patients Tested for MET Amplification and Therapy Response in the MD Anderson Phase I Clinic Clinical Cancer Research ·Denis L. Jardim,Chad Tang,Débora De Melo Gagliato,Gerald S. Falchook,Kenneth R. Hess,Filip Jankú,Siqing Fu,Jennifer J. Wheler,Ralph Zinner,Aung Naing,Apostolia M. Tsimberidou,Vijaykumar Holla,Marylin M. Li,Sinchita Roy‐Chowdhuri,Raja Luthra,Ravi Salgia,Razelle Kurzrock,Funda Meric‐Bernstam,David S. Hong	2014	65
9	B acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of disease Modern Pathology ·Jesse Jaso,C. Cameron Yin,Victoria Lu,Ming Zhao,Lynne V. Abruzzo,M. James You,Ya‐Ling Yang,Raja Luthra,L. Jeffrey Medeiros,Gary Lu	2013	8
10	MutatedNPM1in patients with acute myeloid leukemia in remission and relapse Leukemia & lymphoma ·Preetesh Jain,Hagop M. Kantarjian,Keyur P. Patel,Stefan Faderl,Guillermo Garcia‐Manero,Ohad Benjamini,Gautam Borthakur,Naveen Pemmaraju,Tapan M. Kadia,Naval Daver,Aziz Nazha,Raja Luthra,Sherry Pierce,Jörge E. Cortes,Farhad Ravandi	2013	30
11	Tyrosine Kinase Inhibitors as Initial Therapy for Patients With Chronic Myeloid Leukemia in Accelerated Phase Clinical Lymphoma Myeloma & Leukemia ·Maro Ohanian,Hagop M. Kantarjian,Alfonso Quintás‐Cardama,Elias Jabbour,Lynne V. Abruzzo,Srđan Verstovšek,Gautam Borthakur,Farhad Ravandi,Guillermo Garcia‐Manero,Richard E. Champlin,Sherry Pierce,Mona Lisa Alattar,Long Trinh,Raja Luthra,Alessandra Ferrajoli,Tapan M. Kadia,Susan O’Brien,Jörge E. Cortes	2013	34
12	Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring Haematologica ·Raja Luthra,Keyur P. Patel,Neelima G. Reddy,Varan Haghshenas,Mark J. Routbort,Michael A. Harmon,Bedia A. Barkoh,Rashmi Kanagal‐Shamanna,Farhad Ravandi,Jörge E. Cortes,Hagop M. Kantarjian,L. Jeffrey Medeiros,Rajesh R. Singh	2013	124
13	Clinical and proteomic characterization of acute myeloid leukemia with mutated RAS Cancer ·Tapan M. Kadia,Hagop M. Kantarjian,Steven M. Kornblau,Gautam Borthakur,Stefan Faderl,Emil J. Freireich,Raja Luthra,Guillermo Garcia‐Manero,Sherry Pierce,Jörge E. Cortes,Farhad Ravandi	2012	30
14	Trichilemmomas show loss of PTEN in Cowden syndrome but only rarely in sporadic tumors Journal of Cutaneous Pathology ·Tariq Al‐Zaid,Jeremy S. Ditelberg,Víctor G. Prieto,Dina Lev,Raja Luthra,Michael A. Davies,A. Hafeez Diwan,Wei‐Lien Wang,Alexander J. Lazar	2012	23
15	FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia American Journal of Hematology ·Naval Daver,Paolo Strati,Elias Jabbour,Tapan M. Kadia,Raja Luthra,Sa Wang,Keyur P. Patel,Farhad Ravandi,Jörge E. Cortes,Xiao Qin Dong,Hagop M. Kantarjian,Guillermo Garcia‐Manero	2012	82
16	Impact of numerical variation in FMS‐like tyrosine kinase receptor 3 internal tandem duplications on clinical outcome in normal karyotype acute myelogenous leukemia Cancer ·Gautam Borthakur,Hagop M. Kantarjian,Keyur P. Patel,Farhad Ravandi,Wei Qiao,Stefan Faderl,Tapan M. Kadia,Raja Luthra,Sherry Pierce,Jörge E. Cortes	2012	13
17	Utility of the World Heath Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrow Modern Pathology ·Malisha R. Johnson,Srđan Verstovšek,Jeffrey L. Jorgensen,Taghi Manshouri,Raja Luthra,Dan Jones,Carlos E. Bueso‐Ramos,L. Jeffrey Medeiros,Yang O. Huh	2008	28
18	Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome Modern Pathology ·Russell R. Broaddus,Patrick M. Lynch,Karen H. Lu,Raja Luthra,Sara J Michelson	2004	57
19	Imatinib Mesylate for Patients (pts) with Hypereosinophilic Syndrome (HES) and Systemic Mastocytosis (SM): A Phase II Trial. Blood ·Elias Jabbour,Hagop M. Kantarjian,Srđan Verstovšek,Dan Jones,Susan O’Brien,Raja Luthra,Farhad Ravandi‐Kashani,William G. Wierda,Francis J. Giles,Mary Beth Rios,Jörge E. Cortes	2004	1
20	Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low β2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase Annals of Oncology ·José Rodríguez,William Pugh,Jorge Romaguera,Raja Luthra,Fredrick B. Hagemeister,Peter McLaughlin,Maria Alma Rodriguez,F Swan,Fernando Cabanillas	1994	21

About Raja Luthra

Raja Luthra is a scholar working on Genetics, Hematology and Cancer Research, having authored 54 papers that have together received 1.7k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (17 papers), Chronic Lymphocytic Leukemia Research (15 papers), Acute Myeloid Leukemia Research (12 papers), Cancer Genomics and Diagnostics (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Eosinophilic Disorders and Syndromes (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Hematology (607 citations), Genetics (439 citations) and Cancer Research (468 citations). Raja Luthra has collaborated with scholars based in United States, Malaysia and Italy. Frequent co-authors include Hagop M. Kantarjian, Jörge E. Cortes, Keyur P. Patel, Farhad Ravandi, Srđan Verstovšek, Patrick M. Lynch, Mark J. Routbort, Russell R. Broaddus, Guillermo Garcia‐Manero and Tapan M. Kadia. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact